Knight Therapeutics | GUD - PE价格收益

金融业

CAD

CAD 1.05B

现金及等价物

CAD 76.45M

CAD 82.22M

CAD 394.84M

CAD 165.26M

CAD 77.91M

CAD 6.21M

CAD 24.45M

698

EPS每股收益

CAD 0.13

股本和储备

CAD 767.27M

CAD 64.72M

债务利息支出

CAD 3.92M

CAD 2.46M

CAD 57.78M

CAD 955.05M

CAD -3.79M

CAD 126.9M

CAD 6.21M

普通股股本

CAD 99.68M

257.34

CAD -1.92M

CAD 133.11M

销售和管理费用

CAD 35.45M

CAD 95.4M

贸易债权人

CAD 125.76M

应收帐款人

CAD 183M

	Pe	更改		日
Acasti Pharma	9.94		0.08	2021-03
Akebia Therapeutics	1.63K		1.6K	2025-12
Aurora Cannabis	23.27		0	2025-09
Cronos Group	120.93		97.04	2026-03
Dianthus Therapeutics	3.8		1.53	2024-09
Ionis Pharmaceuticals	396.15		79.28	2022-09
IQVIA Holdings	19.37		7.21	2026-03
Knight Therapeutics	257.34		166.24	2025-12
Moderna	27.22		14.51	2023-06
Organigram Holdings	235		224.49	2025-09
Organon & Co	3.75		0.87	2025-12
Revvity	30.79		19.08	2026-03
Tectonic Therapeutic	4.01		0.63	2024-03
Tilray	11.56		80.19	2025-09
Viatris	14.61		4.21	2026-03